SVG Sprites

Press

LDPN in the News 06.23.2021

Senator Duckworth: Senate must pass bill to enable the government to negotiate lower prescription drug prices

Sen. Tammy Duckworth (D-Ill.), opinion contributor

Every time I hear a constituent struggling to afford next month’s medications, wondering whether they’ll have to choose between paying for a lifesaving prescription and paying rent, the same question — the same frustration — rushes through my mind.

LDPN in the News 06.22.2021

Common Dreams: Key Senate Democrat Applauded for Manifesto on Reducing Drug Costs

Progressives pushing Congress and President Joe Biden to enact drug pricing reforms that lower costs applauded a two-page principles document published Tuesday by Senate Finance Committee Chair Ron Wyden.

“It’s time for Congress to hold Big Pharma accountable for price-gouging at the pharmacy counter.”

LDPN in the News 06.22.2021

San Diego Union-Tribune: Congress should support the Lower Drug Costs Now Act for affordable medicine

By Annemarie Gibson, a mother of two children 13 and 11 years old living with Type 1 diabetes. She lives in Mira Mesa.

 

As the mom of two children with Type 1 diabetes, I constantly worry: What if my husband and I lose our health coverage or can no longer afford the medicines they need because drug corporations raise the prices beyond our means?Our sons,

Press Releases 06.22.2021

Senate Finance drug reform principles are an important step. Now we need action.

Statement from Margarida Jorge, campaign director for Lower Drug Prices Now, on the Senate Finance Committee’s Principles for Drug Pricing Reform:

“The principles for drug pricing reform released by the Senate Finance Committee are a big step in the right direction and demonstrate that Chairman Wyden plans to prioritize patients,

Press Releases 06.11.2021

Biogen’s price gouging is why Congress must pass HR3, now.

The hefty price tag for Biogen’s new Alzheimer’s drug proves that when drug corporations have monopoly power to set prices, they will set them ridiculously high. Biogen is selling false hopes, rather than clinical results, to desperate families — but still stands to make a profit. Already since the announcement of the FDA’s approval, Biogen’s share price has skyrocketed.  

LDPN in the News 06.08.2021

Portland Press Herald Commentary: Congress should stop rewarding Big Pharma with tax breaks for gouging patients

By Emily Ingwersen, Special to the Press Herald

Thousands of Mainers and millions of Americans recently filed taxes. As a small-business owner, I probably think more about taxes than the average Mainer, and every tax day I find myself reflecting on all the important investments that taxes make possible in our communities.

LDPN in the News 06.08.2021

Orlando Sentinel Opinion: Biden’s health coverage improvements don’t go far enough

President Joe Biden recently said: “Health care should be a right, not a privilege in America.” Having spent a lifetime navigating Florida’s patchwork of health coverage options and providers, I couldn’t agree more.

Nearly 40 years ago I gave birth while covered by Medicaid,

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles